carcinoma verrucoso: uma variante clínico-histopatológica do carcinoma espinocelular verrucous carcinoma: a clinical-histopathologic variant of squamous cell carcinoma
Clicks: 175
ID: 164907
2004
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
2.4
/100
8 views
8 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
O carcinoma verrucoso é uma rara e indolente forma do carcinoma espinocelular descrita por Ackerman em 1948. Sua localização preferencial é a cavidade oral. Clinicamente manifesta-se como lesão verrucosa, de progressivo e lento crescimento e bom prognóstico. O tratamento de escolha é a exérese cirúrgica, devendo o paciente ser regularmente acompanhado devido ao risco de recorrências.
Verrucous carcinoma is a rare and indolent variant of the squamous cell carcinoma described by Ackerman in 1948. The oral cavity is a most common site. Clinically, it presents most often as a slow-growing verrucous lesion. The prognosis is good. Treatment of choice is surgery. Patients require frequent reevaluation because recurrences may occur.
Verrucous carcinoma is a rare and indolent variant of the squamous cell carcinoma described by Ackerman in 1948. The oral cavity is a most common site. Clinically, it presents most often as a slow-growing verrucous lesion. The prognosis is good. Treatment of choice is surgery. Patients require frequent reevaluation because recurrences may occur.
| Reference Key |
zanini2004anaiscarcinoma
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Maurício Zanini;Cláudio Wulkan;Francisco Macedo Paschoal;Marisa Homem de Mello Maciel;Carlos D´Apparecida S. Machado Filho |
| Journal | Theriogenology |
| Year | 2004 |
| DOI |
10.1590/S0365-05962004000500013
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.